173 related articles for article (PubMed ID: 11476048)
21. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.
Cazzola M; Donner CF
Drugs; 2000 Aug; 60(2):307-20. PubMed ID: 10983735
[TBL] [Abstract][Full Text] [Related]
22. [COPD treatment by drugs].
Nafti S
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967
[No Abstract] [Full Text] [Related]
23. Should long-acting beta 2-agonists be considered an alternative first choice option for the treatment of stable COPD?
Cazzola M; Matera MG
Respir Med; 1999 Apr; 93(4):227-9. PubMed ID: 10464885
[No Abstract] [Full Text] [Related]
24. Nebulisers for chronic obstructive pulmonary disease.
O'Driscoll BR
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S49-52. PubMed ID: 9155851
[No Abstract] [Full Text] [Related]
25. [When beta-mimetic and anticholinergic agents fail in COPD. More air with theophylline].
MMW Fortschr Med; 2004 Apr; 146(18):57. PubMed ID: 15366477
[No Abstract] [Full Text] [Related]
26. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; ten Hacken N
Clin Evid; 2005 Jun; (13):1923-47. PubMed ID: 16135316
[No Abstract] [Full Text] [Related]
27. Drugs in the treatment of asthma.
Svedmyr N; Simonsson BG
Pharmacol Ther B; 1978; 3(4):397-440. PubMed ID: 32558
[No Abstract] [Full Text] [Related]
28. [Clinical aspects of anticholinergic agents].
Friedman M
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
[No Abstract] [Full Text] [Related]
29. Chronic obstructive pulmonary disease.
Kerstjens H; Postma D; ten Hacken N
Clin Evid; 2006 Jun; (15):2077-100. PubMed ID: 16973079
[No Abstract] [Full Text] [Related]
30. Management of chronic obstructive pulmonary disease.
Donohue JF
Curr Opin Pulm Med; 1995 Mar; 1(2):129-43. PubMed ID: 15786603
[TBL] [Abstract][Full Text] [Related]
31. [Inflammatory mediators in the pathogenesis of obstructive bronchial diseases: consequences for therapy].
Hahn HL
Verh Dtsch Ges Inn Med; 1988; 94():364-75. PubMed ID: 2905102
[No Abstract] [Full Text] [Related]
32. Considerations in office management of chronic obstructive pulmonary disease.
Schwartz AM
J Am Osteopath Assoc; 1981 Aug; 80(12 Suppl):866-9. PubMed ID: 6115835
[No Abstract] [Full Text] [Related]
33. [Bronchodilator treatment of chronic obstructive bronchopneumopathies].
Meslier N; Racineux JL
Rev Mal Respir; 1993; 10(2):79-85. PubMed ID: 8099224
[No Abstract] [Full Text] [Related]
34. [Drug therapy of chronic phase in chronic obstructive pulmonary disease].
Kawashiro T
Nihon Naika Gakkai Zasshi; 1995 May; 84(5):735-9. PubMed ID: 7616083
[No Abstract] [Full Text] [Related]
35. [Anti-allergy therapy in children].
Nicolie B; Declerck A; Drouet M
Allerg Immunol (Paris); 2001 Mar; 33(3):127-41. PubMed ID: 11386127
[TBL] [Abstract][Full Text] [Related]
36. [COPD therapy in coronary heart disease patients. How safe are bronchodilators?].
Stiefelhagen P
MMW Fortschr Med; 2009 Oct; 151(44):22. PubMed ID: 19957471
[No Abstract] [Full Text] [Related]
37. Cimetidine-theophylline interaction: report of four patients.
Bauman JH; Kimelblatt BJ; Caraccio TR; Silverman HM; Simon GI; Beck GJ
Ann Allergy; 1982 Feb; 48(2):100-2. PubMed ID: 6121526
[TBL] [Abstract][Full Text] [Related]
38. Choice of bronchodilator therapy in chronic obstructive pulmonary disease.
Rennard SI
Respirology; 1997; 2 Suppl 1():S11-5. PubMed ID: 9400689
[TBL] [Abstract][Full Text] [Related]
39. [Current approaches to the treatment of chronic obstructive pulmonary diseases].
Leshchenko IV; Ovcharenko SI
Ter Arkh; 2003; 75(8):83-7. PubMed ID: 14520861
[No Abstract] [Full Text] [Related]
40. [Chronic obstructive bronchitis (COPD). Are anticholinergic drugs underestimated?].
MMW Fortschr Med; 2001 Mar; 143(9):57. PubMed ID: 11294177
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
